Resolute Partners Group
- SEC CIK
- 0001800217
- Latest filing
- Aug 14, 2026
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by Resolute Partners Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings
- Shares (Q2 2026)
- 57,526
- Value
- $451.6K
- % of portfolio
- 0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 57,526 | $451.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 57,526 | $200.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 57,526 | $196.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 57,526 | $289.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 57,526 | $197.3K | <0.1% | −4,050−6.6% | Reduced | Holders |
| Q1 2025 | 61,576 | $137.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 61,576 | $180.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 61,576 | $160.1K | <0.1% | +4,050+7.0% | Added | Holders |
| Q2 2024 | 57,526 | $170.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 57,526 | $260.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 57,526 | $328.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 57,526 | $264.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 57,526 | $371.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 57,526 | $433.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 57,526 | $582.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 57,526 | $569.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 57,526 | $613.0K | 0.1% | +14,086+32.4% | Added | Holders |
| Q1 2022 | 43,440 | $424.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 43,440 | $621.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 43,440 | $871.0K | 0.1% | +43,440 | New | Holders |